Biotherapeutics News and Research

RSS
UNC-Chapel Hill secures $65 million NIH grant for establishing Antiviral Drug Discovery Center

UNC-Chapel Hill secures $65 million NIH grant for establishing Antiviral Drug Discovery Center

NIH awards $577 million to establish AViDD Centers for Pathogens of Pandemic Concern

NIH awards $577 million to establish AViDD Centers for Pathogens of Pandemic Concern

Dapagliflozin did not reduce risks in patients hospitalized with COVID-19

Dapagliflozin did not reduce risks in patients hospitalized with COVID-19

Flow Eighteen38 receives €5 million EUR (c.$5.58 million USD) to expand production and biophysical capabilities

Flow Eighteen38 receives €5 million EUR (c.$5.58 million USD) to expand production and biophysical capabilities

Harvard’s new kidney engineering technology licensed to San Diego-based Trestle Biotherapeutics

Harvard’s new kidney engineering technology licensed to San Diego-based Trestle Biotherapeutics

Antibiotic treatment after birth affects a newborn's gut microbiome

Antibiotic treatment after birth affects a newborn's gut microbiome

Accurate prediction of COVID-19 outbreaks using location data from mobile devices

Accurate prediction of COVID-19 outbreaks using location data from mobile devices

Oral supplement appears to promote muscle endurance and mitochondrial health in humans

Oral supplement appears to promote muscle endurance and mitochondrial health in humans

Big Tuna and automated buffer exchange: An interview with Unchained Labs

Big Tuna and automated buffer exchange: An interview with Unchained Labs

Sandwich automated buffer exchange into protein, AAV or LNP workflows with         Big Tuna

Sandwich automated buffer exchange into protein, AAV or LNP workflows with Big Tuna

Success of covid antiviral pills hinges on access to speedy and accurate tests

Success of covid antiviral pills hinges on access to speedy and accurate tests

How to achieve fast, accurate and reliable quantitation of AAV serotypes

How to achieve fast, accurate and reliable quantitation of AAV serotypes

MHRA approves first oral antiviral for the treatment of COVID-19

MHRA approves first oral antiviral for the treatment of COVID-19

RedShift BioAnalytics Celebrates Opening of StructIR Scientific Services Lab with the Launch of the StructIR Lab Grant Program

RedShift BioAnalytics Celebrates Opening of StructIR Scientific Services Lab with the Launch of the StructIR Lab Grant Program

First of its kind ‘living medicine’ designed to treat antibiotic-resistant bacteria on medical implants

First of its kind ‘living medicine’ designed to treat antibiotic-resistant bacteria on medical implants

Gyros Protein Technologies introduces Gyrolab AAV9 Titer Kit to support AAV-based cell and gene therapy production

Gyros Protein Technologies introduces Gyrolab AAV9 Titer Kit to support AAV-based cell and gene therapy production

Novel polyclonal antibody therapy meets the criteria for graduation to phase 3 in ACTIV-2 trial

Novel polyclonal antibody therapy meets the criteria for graduation to phase 3 in ACTIV-2 trial

A daily pill to treat covid could be just months away, scientists say

A daily pill to treat covid could be just months away, scientists say

Multiple sclerosis patients elicit robust T-cell responses to mRNA COVID-19 vaccines

Multiple sclerosis patients elicit robust T-cell responses to mRNA COVID-19 vaccines

Temple research paves the way for first Phase 1/2 clinical trials of CRISPR-based therapy for HIV

Temple research paves the way for first Phase 1/2 clinical trials of CRISPR-based therapy for HIV